LASAACI 2021 Fall Symposia
It is an exciting time in the field of allergy and immunology! This CME program is designed to allow attendees to continue exploring the Immunology Frontier. Covered topics include current and emerging treatments in atopic dermatitis, oral immunotherapy and asthma management.
Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Allergy, Asthma & Immunology (ACAAI) and the Los Angeles Society of Allergy, Asthma & Clinical Immunology, Inc. The American College of Allergy, Asthma, and Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 4 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity
Commercial Support
This activity is supported in part by medical education grants from Astra Zeneca and Genentech.
Target Audience
Practicing allergists
Allied health professionals
Learning Objectives
Upon completion of this activity the participant should be able to:
- Describe potential benefits and risks of JAK inhibitors in atopic dermatitis
- Identify the key features for safe and successful implementation of OIT in the office-based setting
- Recognize the pathophysiology of airway epithelial inflammation
Mark Boguniewicz, MD – Speaker
Consultant: AbbVie,
Advisory Board Member: Eli Lily, Pfizer, Regeneron, Sanofi, Janssen, LEO Pharma
Research Grant: Regeneron, Incyte
Warner Carr, MD – Speaker
Consultant: AstraZeneca, Teva, Merz
Speaker: AstraZeneca, DBV Technologies, Merz
Matthew Greenhawt, MD, MBA, MSc – Speaker
Advisory Board Member: DBV Technologies, Sanofi/Regeneron, Nutricia,Novartis, Aquestive, Allergenis, Prota, Pfizer,ALK-Abello
Associate Editor: ACAAI
Speaker: MedLearning Group, ImSci, ConnecticutChildren’s Medical Center
Consultant: Aquestive, Allergenis
Scientific Advisory Board: National Peanut Board
Member: Joint Taskforce on Practice Parameters
Travis A. Miller, MD – Speaker
Independent Contractor: DBV Technologies
Speaker: Genentech, Optinose
Raffi Tachdjian, MD – Planner
Speaker: Sanofi Regeneron, GSK, Takeda, CSL Behring, Pharming, Biocryst
Advisory Board Member: Sanofi Regeneron, Takeda, CSL Behring, Pharming, Biocryst, Allakos, Ionis
Sonal Patel, MD – Planner
Speaker: Sanofi Regeneron
Rita Kachru, MD – Planner
Independent Contractor : Aimmune, Genentech
Jonathan Corren, MD – Planner
Speaker: AstraZeneca, Genentech, Novartis, Regeneron, Sanofi
Independent Contractor: AstraZeneca, Genentech, Novartis, Optinose, Regeneron, Sanofi, Teva
Consultant: AstraZeneca, Novartis, Regeneron, Sanofi
Advisory Board Member: AstraZeneca, Novartis, Optinose, Regeneron, Sanofi
The following have no relevant financial relationships to disclose:
Danica Schulte, MD – Planner, Moderator
Sheila M. Bonilla, MD – Planner
Dean Chiang, MD – Planner
Edward Hu, MD – Planner
Caroline Spagnola, MD – Planner
Andrew K. Wong, MD – Planner
Joseph Yusin, MD – Planner
Karol Anderson – Planner
Available Credit
- 4.00 AMA PRA Category 1 Credit™
- 4.00 Attendance
- 4.00 CBRN